Phyllanthin

Phyllanthin’s strongest and most distinctive signal — and, unlike hypophyllanthin, one shown for the molecule alone. Isolated phyllanthin reduced carbon-tetrachloride hepatotoxicity and experimental liver fibrosis in mice ^{1Reference 1Krithika R et al. · 2015AnimalMechanism of protective effect of phyllanthin against carbon tetrachloride-induced hepatotoxicity and experimental liver fibrosis in miceView study →}, with the mechanism traced to down-regulation of TNF-α/NF-κB and the pro-fibrotic factor TGF-β1 ^{2Reference 2Chandran G et al. · 2016Phyllanthin inhibits CCl₄-mediated oxidative stress and hepatic fibrosis by down-regulating TNF-α/NF-κB and the pro-fibrotic factor TGF-β1View study →} — the pharmacological embodiment of the traditional Phyllanthus liver reputation.

Gap: rodent CCl₄ models only; no human isolate data, and the clinical hepatitis-B evidence is for the whole extract (largely negative in the best trials), not phyllanthin ^{1,2Reference 1Krithika R et al. · 2015AnimalMechanism of protective effect of phyllanthin against carbon tetrachloride-induced hepatotoxicity and experimental liver fibrosis in miceView study →Reference 2Chandran G et al. · 2016Phyllanthin inhibits CCl₄-mediated oxidative stress and hepatic fibrosis by down-regulating TNF-α/NF-κB and the pro-fibrotic factor TGF-β1View study →}.

A coherent NF-κB-centred story that overlaps mechanistically with the fibrosis work. Isolated phyllanthin suppressed LPS-induced pro-inflammatory responses in U937 macrophages via NF-κB/MAPK/PI3K-Akt ^{3Reference 3Harikrishnan H et al. · 2018Phyllanthin from Phyllanthus amarus inhibits LPS-induced proinflammatory responses in U937 macrophages via downregulation of NF-κB/MAPK/PI3K-Akt signallingView study →}, with whole-extract confirmation in human macrophages ^{4Reference 4Harikrishnan H et al. · 2018Anti-inflammatory effects of Phyllanthus amarus through inhibition of NF-κB, MAPK and PI3K-Akt signalling in LPS-induced human macrophagesView study →}; the phyllanthin+hypophyllanthin pair also eased ovalbumin-induced asthma (↓ IgE, iNOS, TNF-α; ↑ Nrf2) ^{5Reference 5Wu W et al. · 2019Phyllanthin and hypophyllanthin from Phyllanthus amarus ameliorate the immune-inflammatory response in ovalbumin-induced asthmaView study →}.

Gap: in-vitro / rodent readouts with downstream markers only, and the asthma study pairs it with a co-lignan ^{3,5Reference 3Harikrishnan H et al. · 2018Phyllanthin from Phyllanthus amarus inhibits LPS-induced proinflammatory responses in U937 macrophages via downregulation of NF-κB/MAPK/PI3K-Akt signallingView study →Reference 5Wu W et al. · 2019Phyllanthin and hypophyllanthin from Phyllanthus amarus ameliorate the immune-inflammatory response in ovalbumin-induced asthmaView study →}.

The distinctive shared-with-hypophyllanthin angle, but phyllanthin carries its own interaction paper. Phyllanthin (with hypophyllanthin) inhibited P-glycoprotein efflux but not MRP2 in Caco-2 cells ^{6Reference 6Sukhaphirom N et al. · 2013Phyllanthin and hypophyllanthin inhibit the function of P-gp but not MRP2 in Caco-2 cellsView study →}, and a dedicated study characterised a potential P-gp-mediated herb-drug interaction at the intestinal absorptive barrier ^{7Reference 7Sukhaphirom N et al. · 2019Potential P-glycoprotein-mediated herb-drug interaction of phyllanthin at the intestinal absorptive barrierView study →} — a two-way flag (it may raise absorption of itself and of co-administered P-gp substrates).

Gap: in-vitro / intestinal-barrier models; no in-vivo interaction or human PK confirmation, so this is theoretical, not clinically documented ^{6,7Reference 6Sukhaphirom N et al. · 2013Phyllanthin and hypophyllanthin inhibit the function of P-gp but not MRP2 in Caco-2 cellsView study →Reference 7Sukhaphirom N et al. · 2019Potential P-glycoprotein-mediated herb-drug interaction of phyllanthin at the intestinal absorptive barrierView study →}.

Mechanistically continuous with the P-gp story — MDR reversal is the anticancer face of efflux-pump inhibition rather than direct cytotoxic potency. Phyllanthus amarus lignans showed cytotoxic and multidrug-resistance-reversing action ^{8Reference 8Leite DF et al. · 2006The cytotoxic effect and the multidrug-resistance reversing action of lignans from Phyllanthus amarusView study →}, and phyllanthin+hypophyllanthin synergised doxorubicin against resistant breast-cancer cells ^{9Reference 9Abdel-Sattar OE et al. · 2023Hypophyllanthin and phyllanthin from Phyllanthus niruri synergise doxorubicin’s anticancer properties against resistant breast-cancer cellsView study →}.

Gap: cell lines only, in pair/fraction studies, with no in-vivo tumour or clinical data ^{8,9Reference 8Leite DF et al. · 2006The cytotoxic effect and the multidrug-resistance reversing action of lignans from Phyllanthus amarusView study →Reference 9Abdel-Sattar OE et al. · 2023Hypophyllanthin and phyllanthin from Phyllanthus niruri synergise doxorubicin’s anticancer properties against resistant breast-cancer cellsView study →}.

The lipid/anti-adipogenic angle is essentially whole-extract: standardised P. niruri extract (phyllanthin as marker) eased NAFLD progression and lowered atherosclerotic risk in rats ^{12Reference 12Al Zarzour RH et al. · 2017AnimalPhyllanthus niruri standardised extract alleviates the progression of non-alcoholic fatty liver disease and decreases atherosclerotic risk in ratsView study →}. The one metabolic effect attributed specifically to phyllanthin is uricosuric — it raised urinary uric-acid clearance, an effect blocked by pyrazinamide (acting on excretion, not synthesis) ^{13Reference 13Murugaiyah V · 2009Mechanisms of the antihyperuricemic effect of Phyllanthus niruri and its lignan constituentsView study →}.

Gap: no dedicated isolated-phyllanthin antihyperlipidemic study — the lipid data ride on the extract; the uricosuric work is a single mechanistic paper ^{12,13Reference 12Al Zarzour RH et al. · 2017AnimalPhyllanthus niruri standardised extract alleviates the progression of non-alcoholic fatty liver disease and decreases atherosclerotic risk in ratsView study →Reference 13Murugaiyah V · 2009Mechanisms of the antihyperuricemic effect of Phyllanthus niruri and its lignan constituentsView study →}.